Combination chemotherapy with capecitabine (C), irinotecan (I), oxaliplatin (O), and bevacizumab (B; XELOXIRIA) as first-line treatment of metastatic colorectal cancer (MCRC): Preliminary results of a phase I-II trial

Journal article

Peer reviewed

S. Bazarbashi, A. H. Aljubran, H. Soudy, A. Darwish, A. Eltigani, M. Nabil-Ahmed, W. Edesa, M. Almubarak, A. Abu sabaa and M. Shoukri

Journal of clinical oncology, Vol.29(15_suppl), pp.e14073-e14073

20/05/2011

Abstract

Abstract only

1 Record Views

Title: Combination chemotherapy with capecitabine (C), irinotecan (I), oxaliplatin (O), and bevacizumab (B; XELOXIRIA) as first-line treatment of metastatic colorectal cancer (MCRC): Preliminary results of a phase I-II trial
Creators - without role: S. Bazarbashi
A. H. Aljubran
H. Soudy
A. Darwish
A. Eltigani
M. Nabil-Ahmed
W. Edesa
M. Almubarak
A. Abu sabaa
M. Shoukri
Publication Details: Journal of clinical oncology, Vol.29(15_suppl), pp.e14073-e14073
Identifiers: 9921271608331
Academic Unit: King Abdulaziz University; King Saud Bin Abdulaziz University for Health Sciences
Language: English
Resource Type: Journal article